Oncotarget was originally initiated in 2010 as a traditional journal with multiple disciplines. One of the main factors that has proceeded to make Oncotarget rather infamous is its dedication to its core value: democratization.
One of the most strongest shows of evidence is the Creative Commons Attribution 3.0 License, this allows people to take the research studies from Oncotarget and share it more easily with others.
Bearing in mind, there are other suggested studies that that Oncotarget has taken a focus towards besides just oncology: other topics of importance are gerotargeting, cell death, autophagy, pathology, immunology, and other topics of related interest.
This democratized approach where research studies can be easily shared allows breakthroughs from Oncotarget to happen much faster than it normally would.
This is perfect because ultimately, this saves time.
Another factor of the democratization approach is that Oncotarget is listed in recognized scientific indexes.
Oncotarget is constantly staying up-to-current-affairs by archiving published experiments each and every day. Check Oncotarget at scimagojr.com
The free and open access is a core value that Oncotarget takes rather seriously.
Moving Forward in the Media Landscape
Oncotarget proceeds with its stated objectives in regards to its media platform.
In fact, earlier in 2017, Oncotarget had stated that their goal was to transform the journal altogether into a twice-weekly publication.
One notable achievement has been reached.
The end result with the notable increase the frequency of their publication is the media consumers won’t have to worry about hiatuses.
The following achievement is that Oncotarget has created its own podcast. The overall purpose of that podcast is to detail its findings in podcasting format.
People will be able to listen to accomplishments and the breakthroughs that have been done and documented in Oncotarget.
The podcast can be listened to on podcasting platforms such as Stitcher, Soundcloud, Player.FM, and iTunes.
What Are Other Achievements that Oncotarget Made?
Oncotarget has been involved with current achievements, as well.
Oncotarget has been able to share that a few Oncotarget researchers have been able to identify new therapeutic strategies to treat thyroid cancer.
Oncotarget still has remained indexed by most scientific databases such as Biological Abstracts, Embase, BIOSIS Previews, and Scopus.
Oncotarget’s accomplishments should defintely be acclaimed.
The Concept of Democratization
Due to the democratized nature of the journal, Oncotarget has allowed for its researched and published experiments to be shared much more easily and more expediently. Watch this video on Youtube.
Democratization is a cause and a core value that Oncotarget heavily abides by.